Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:224 Flecainide
Search Links: General Info : Protocols : Patient Info

DescriptionCardiac anti-arrhythmic drug. For monitoring purposes, blood should not be drawn until a steady state has been attained.
IndicationTherapeutic drug monitoring (TDM) of anti-arrhythmic drugs
Additional InfoUsed for treatment of AV nodal reciprocating tachycardia. Normal dose in adults is 200-400 mg/day. Excreted unchanged in urine.
Concurrent Testsna
Dietary Requirementsna

InterpretationHalf life is 14 hours, 20 hours if have ventricular arrhythmias. Steady state plasma levels achieved after 3-5 days of treatment.

Ref. Range (Male)0.15 - 0.9
Ref. Range (Female)0.15 - 0.9
Ref. Range (Paed)
Ref. Range Notes
Unitsmg/L


IP Acute TAT- Contact Laboratory
IP Routine TATAt least 1 week
GP Acute TAT- Contact Laboratory
GP Routine TATAt least 1 week
Turnround CommentRobert Haddon:HutchingsAD@cardiff.ac.uk
Originally edited by : JHB. Last edited on 22/11/2018 12:04:46. Published By on 22/11/2017 12:04:46.